Myostatin Inhibitors: Panacea or Predicament for Musculoskeletal Disorders?
Joonho Suh, Yun-Sil Lee
J Bone Metab. 2020;27(3):151-165.   Published online 2020 Aug 31     DOI: https://doi.org/10.11005/jbm.2020.27.3.151
Citations to this article as recorded by Crossref logo
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Buel D Rodgers, Christopher W Ward
Endocrine Reviews.2022; 43(2): 329.     CrossRef
Therapeutic approaches to preserve the musculature in Duchenne Muscular Dystrophy: The importance of the secondary therapies
Giuseppe Angelini, Giada Mura, Graziella Messina
Experimental Cell Research.2022; 410(2): 112968.     CrossRef
Adeno-associated virus-mediated expression of an inactive CaMKIIβ mutant enhances muscle mass and strength in mice
Takahiro Eguchi, Yuji Yamanashi
Biochemical and Biophysical Research Communications.2022; 589: 192.     CrossRef
The Role of Lifestyle Intervention, in Addition to Drugs, for Diabetic Kidney Disease with Sarcopenic Obesity
Shu-Hua Chen, Yao-Jen Liang
Life.2022; 12(3): 380.     CrossRef
The Evolution of Complex Muscle Cell In Vitro Models to Study Pathomechanisms and Drug Development of Neuromuscular Disease
Jana Zschüntzsch, Stefanie Meyer, Mina Shahriyari, Karsten Kummer, Matthias Schmidt, Susann Kummer, Malte Tiburcy
Cells.2022; 11(7): 1233.     CrossRef
MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
Eun Ju Lee, Sibhghatulla Shaikh, Mohammad Hassan Baig, So-Young Park, Jeong Ho Lim, Syed Sayeed Ahmad, Shahid Ali, Khurshid Ahmad, Inho Choi
International Journal of Molecular Sciences.2022; 23(8): 4222.     CrossRef
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients
Graziana Colaianni, Angela Oranger, Manuela Dicarlo, Roberto Lovero, Giuseppina Storlino, Patrizia Pignataro, Antonietta Fontana, Francesca Di Serio, Angelica Ingravallo, Giuseppe Caputo, Alfredo Di Leo, Michele Barone, Maria Grano
Frontiers in Endocrinology.2022;[Epub]     CrossRef
Randomized Phase 2 Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Florian P. Thomas, Thomas H. Brannagan, Russell J. Butterfield, Urvi Desai, Ali A. Habib, David N. Herrmann, Katy J. Eichinger, Nicholas E. Johnson, Chafic Karam, Alan Pestronk, Colin Quinn, Michael E. Shy, Jeffrey M. Statland, Sub H. Subramony, David Wal
Neurology.2022; 98(23): e2356.     CrossRef
The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
Jeremy Park, Vera Mcllvain, Jared Rosenberg, Lorin Donovan, Priya Desai, Joon Young Kim
The Korean Journal of Sports Medicine.2022; 40(2): 67.     CrossRef
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Mohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, So-Young Park, Jeong Ho Lim, Hee Jin Chun, Afsha Fatima Qadri, Ye Chan Hwang, Arif Tasleem Jan, Syed Sayeed Ahmad, Shahid Ali, Sibhghatulla Shaikh, Eun Ju Lee, Inho Choi
Frontiers in Physiology.2022;[Epub]     CrossRef
Effects of Muscles on Bone Metabolism—with a Focus on Myokines
Beom-Jun Kim
Annals of Geriatric Medicine and Research.2022; 26(2): 63.     CrossRef
Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Guadalupe Elizabeth Jimenez-Gutierrez, Laura Edith Martínez-Gómez, Carlos Martínez-Armenta, Carlos Pineda, Gabriela Angélica Martínez-Nava, Alberto Lopez-Reyes
Cells.2022; 11(15): 2359.     CrossRef
Insight into the role of myokines and myogenic regulatory factors under hypobaric hypoxia induced skeletal muscle loss
Sukanya Srivastava, Richa Rathor, Som Nath Singh, Geetha Suryakumar
Biomarkers.2022; : 1.     CrossRef
From Barbells to Brawns: The Physiology of Resistance Exercise and Skeletal Muscle Growth
Jeremy Park, Vera Mcllvain, Jared Rosenberg, Lorin Donovan, Priya Desai, Joon Young Kim
The Korean Journal of Sports Medicine.2022; 40(3): 151.     CrossRef
Skeletal Muscle Complications in Chronic Kidney Disease
Ashley D. Troutman, Eliott Arroyo, Kenneth Lim, Ranjani N. Moorthi, Keith G. Avin
Current Osteoporosis Reports.2022;[Epub]     CrossRef
Novel myostatin-specific antibody enhances muscle strength in muscle disease models
Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, Atsunori Ueyama, Yoshinao Ruike, Ken Ohmine, Meiri Shida-Kawazoe, Rie Miyano-Nishizawa, Yuichiro Shimizu, Momoko Okuda, Yuji Hori, Madoka Hayashi, Kenta Haraya, Nobuhiro Ban, Tatsuya Nonaka, Masaki Hon
Scientific Reports.2021;[Epub]     CrossRef
Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
Juha J. Hulmi, Tuuli A. Nissinen, Fabio Penna, Andrea Bonetto
Cells.2021; 10(3): 516.     CrossRef
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Alicja Starosta, Patryk Konieczny
Cellular and Molecular Life Sciences.2021; 78(11): 4867.     CrossRef
Hip fracture and sarcopenia: the need for a new paradigm in drug trials for older adults?
Miles D Witham, Richard M Dodds
The Lancet Healthy Longevity.2021; 2(5): e234.     CrossRef
Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics
Jong Hyeon Yoon, Ki-Sun Kwon
Endocrinology and Metabolism.2021; 36(3): 478.     CrossRef
Advances in research on pharmacotherapy of sarcopenia
Yang Feike, Liu Zhijie, Chen Wei
AGING MEDICINE.2021; 4(3): 221.     CrossRef
Therapeutic Implications of miRNAs for Muscle-Wasting Conditions
Laura Yedigaryan, Maurilio Sampaolesi
Cells.2021; 10(11): 3035.     CrossRef
The Failed Clinical Story of Myostatin Inhibitors against Duchenne Muscular Dystrophy: Exploring the Biology behind the Battle
Emma Rybalka, Cara Timpani, Danielle Debruin, Ryan Bagaric, Dean Campelj, Alan Hayes
Cells.2020; 9(12): 2657.     CrossRef